V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 180005180 | 180003001 | null | null | null | null | 2019-12-16 | Docetaxel 75mg/m2 (21 day) | null | null | TEMOZOLOMIDE | 101125274 |
| 180005202 | 180003004 | null | null | null | 2019-01-04 | 2019-01-04 | Paclitaxel 7 day | null | null | NB HRNBL-1 ISOTRETINOIN | 100961839 |
| 180005279 | 180003008 | 0 | null | null | null | 2019-04-09 | NB HRNBL-1 TVD | null | null | CETUXIMAB | 100996756 |
| 180005283 | 180003009 | null | null | null | null | 2018-03-14 | LENVATINIB | null | null | NB HRNBL-1 COJEC IND COURSE C | 100001278 |
| 180005302 | 180003012 | null | null | null | 2019-08-23 | 2019-09-04 | CYCLOPHOSPHAMIDE + FLUDARABINE | null | null | CNS MEDBL HR CISPLATIN/VINCRISTINE/CYCLOPHOSPHAMIDE | 100842329 |
| 180005369 | 180003015 | null | null | null | null | 2016-12-22 | Liposomal Doxorubicin 40mg/m2 | null | null | FLUOROURACIL + OXALIPLATIN | 101475349 |
| 180005736 | 180003028 | null | null | null | 2020-10-08 | 2022-04-24 | ETOPOSIDE | null | null | RITUXIMAB | 100859199 |
| 180005766 | 180003029 | null | null | null | null | 2017-09-12 | Carboplatin + Paclitaxel (3 weekly) | null | null | NOT MATCHED | 101797861 |
| 180005772 | 180003030 | null | null | null | 2022-01-19 | 2022-01-26 | NB HRNBL-1 COJEC Ind COURSE B | null | null | CARBOPLATIN | 100115701 |
| 180005789 | 180003032 | null | null | null | 2017-12-15 | 2017-12-20 | LENVATINIB | null | null | VANDETANIB | 101512902 |
| 180005790 | 180003033 | null | null | null | 2017-04-14 | 2017-07-07 | NB BEACON Dinutuximab, Cyclophosphamide and Topotecan | null | null | TEMOZOLOMIDE | 101587585 |
| 180005817 | 180003036 | null | null | null | null | 2020-06-12 | NB HRNBL-1 ch14.18/CHO only (trial) | null | null | FLUOROURACIL + OXALIPLATIN | 101415269 |
| 180005840 | 180003038 | null | null | null | 2020-12-24 | 2021-01-08 | NB Rel CCLG guidelines Cyclo/topo | 99 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101502418 |
| 180005876 | 180003039 | null | null | null | 2016-07-03 | 2016-07-23 | LENVATINIB | null | null | CABOZANTINIB | 100459350 |
| 180005967 | 180003043 | null | null | null | null | 2019-11-16 | null | null | null | NB HRNBL-1 ISOTRETINOIN | 101556250 |
| 180006018 | 180003047 | null | null | null | null | 2018-09-02 | Paclitaxel (2 or 3 weekly) | null | null | VANDETANIB | 101384741 |
| 180006180 | 180003054 | 0 | null | null | 2017-02-28 | 2018-01-06 | NB HRNBL-1 COJEC Ind COURSE C | null | null | GEMCITABINE + NAB-PACLITAXEL | 101423045 |
| 180006214 | 180003055 | null | null | null | null | 2018-07-12 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | GEMCARBO | 100116896 |
| 180006336 | 180003057 | null | null | null | 2021-01-08 | 2021-01-11 | R GCVP | null | null | CARBOPLATIN | 101433986 |
| 180006393 | 180003058 | null | null | null | 2019-06-28 | 2019-10-19 | Rituximab | null | null | LENVATINIB | 100476730 |
| 180006412 | 180003059 | null | null | null | null | 2020-02-17 | Dinutuximab Beta | null | null | NB HRNBL-1 ISOTRETINOIN | 101018774 |
| 180006433 | 180003060 | null | null | null | null | 2016-10-30 | GEMCITABINE + OXALIPLATIN + PACLITAXEL | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE | 101718054 |
| 180006470 | 180003061 | null | null | null | null | 2018-05-19 | Cisplatin+Doxorubicin+Etoposide 28d | null | null | VANDETANIB | 101621966 |
| 180006482 | 180003062 | null | null | null | null | 2020-04-25 | NB BEACON Temozolomide alone | null | null | GEMCITABINE | 101450779 |
| 180006690 | 180003069 | null | null | null | 2019-08-17 | 2019-08-24 | Sorafenib | 2 | null | FLUOROURACIL + OXALIPLATIN | 100488838 |
| 180006703 | 180003070 | null | null | null | null | 2016-03-13 | null | null | null | NB HRNBL-1 ISOTRETINOIN | 101684845 |
| 180006793 | 180003074 | null | null | null | 2020-09-29 | 2020-09-29 | Cisplatin+Doxorubicin+Etoposide 28d | null | null | NB HRNBL-1 CH14.18/CHO(TRIAL) +IL-2 | 100338065 |
| 180006912 | 180003077 | 0 | null | null | 2020-06-05 | 2020-06-19 | STS Rhabdo RMS 2005 2nd Topo Cyclo | null | null | LENVATINIB | 101745337 |
| 180007019 | 180003080 | null | null | null | 2016-03-08 | 2016-04-01 | MITOTANE | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE + MITOTANE | 100527095 |
| 180007034 | 180003082 | null | null | null | 2020-06-19 | 2020-11-22 | IBRUTINIB | null | null | CETUXIMAB | 101678730 |
| 180007055 | 180003083 | null | null | null | null | 2021-06-06 | NB HRNBL-1 Isotretinoin | null | null | NB HRNBL-1 ISOTRETINOIN | 101603611 |
| 180007059 | 180003084 | null | null | null | 2016-08-04 | 2016-08-08 | Hydroxycarbamide | null | null | LENVATINIB | 100440741 |
| 180007114 | 180003086 | null | null | null | 2019-05-10 | 2019-05-12 | Escalated BEACOPP | null | null | PACLITAXEL | 101822671 |
| 180007165 | 180003088 | null | null | null | 2020-04-22 | 2020-04-22 | NB HRNBL-1 BUMEL MAT | null | null | CABOZANTINIB | 100893264 |
| 180007273 | 180003094 | null | null | null | 2018-09-24 | 2018-10-11 | LENVATINIB | null | null | CABOZANTINIB | 100541864 |
| 180007308 | 180003095 | null | null | null | null | 2018-07-14 | NB HRNBL-1 TVD | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE | 101258134 |
| 180007391 | 180003097 | null | null | null | null | 2020-09-15 | CABOZANTINIB | null | null | CARBOPLATIN + PEMETREXED | 100166188 |
| 180007527 | 180003100 | null | null | null | null | 2021-10-30 | Bortezomib + Daratumumab | null | null | CABOZANTINIB | 100606459 |
| 180007867 | 180003105 | null | null | null | null | 2019-07-01 | Dinutuximab Beta | null | null | NB HRNBL-1 ISOTRETINOIN | 101807444 |
| 180008041 | 180003111 | null | null | null | 2022-03-24 | 2022-04-03 | BEAM | null | null | LENVATINIB | 100156298 |
| 180008070 | 180003114 | null | null | null | null | 2018-09-22 | Carboplatin + Paclitaxel (3 weekly) | null | null | SELPERCATINIB | 100807613 |
| 180008150 | 180003116 | null | null | null | 2019-04-21 | 2020-12-02 | NB HRNBL-1 COJEC Ind COURSE A | null | null | DINUTUXIMAB BETA | 101390934 |
| 180008281 | 180003120 | null | null | null | null | 2017-03-05 | Docetaxel | null | null | CAPECITABINE + OXALIPLATIN | 101703650 |
| 180008286 | 180003121 | null | null | null | null | 2017-06-28 | null | null | null | NOT MATCHED | 101688440 |
| 180008364 | 180003123 | null | null | null | 2018-06-24 | 2018-07-01 | null | null | null | PEMETREXED | 100879292 |
| 180008375 | 180003124 | 1.54 | null | null | null | 2016-12-22 | null | null | null | HYDROXYCARBAMIDE | 100486607 |
| 180008440 | 180003127 | null | null | null | null | 2019-01-21 | NB HRNBL-1 COJEC Ind COURSE A | null | null | FLUOROURACIL + OXALIPLATIN | 101358012 |
| 180008568 | 180003132 | null | null | null | 2017-01-24 | 2017-02-04 | CABOZANTINIB | null | null | IRINOTECAN + TEMOZOLOMIDE + DINUTUXIMAB BETA | 101638982 |
| 180008622 | 180003133 | null | null | null | 2021-11-27 | 2021-12-18 | Cetuximab + Encorafenib | null | null | DINUTUXIMAB BETA | 101783556 |
| 180008645 | 180003134 | null | null | null | null | 2019-08-10 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE | 100416811 |